CSI Market
Sign In | Register

Transcode Therapeutics Inc (RNAZ) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RNAZ Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Transcode Therapeutics Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent8.38
Security Deposit0.00
Cash & Short-term Investments8.00
Other Receivables, Net, Current0.00
Grants Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.08
Total Current Assets10.64
Equipment/Property/Plant Net0.76
Goodwill net25.74
Intangible Assets114.30
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Reimbursement Right Asset Current2.30
Operating Lease Right Of Use Asset-
Total Assets151.01
Liabilities
Accounts Payable and Accrued Liabilities, Current LI4.68
Accrued Liabilities, Current1.10
Short-term Debt0.65
Other Liabilities, Current0.00
Total Current Liabilities5.40
Total Long-term Debt0.00
Other liabilities, Noncurrent6.22
Contract With Customer Liability Current0.09
Deferred Income Tax Liabilities Net0.46
Total Liabilities12.65
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock94.70
Retained Earnings / Accumulated Deficit-122.40
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity-27.69
Non-controlling interests & other0.00
Total Stockholder's Equity-27.69
Liabilities & Stockholder's Equity151.01
4 historic quarters locked

Sign in to unlock the full Transcode Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Transcode Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001829635-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.